Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CRDFCRDF
24 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CARDIFF ONCOLOGY INC

CITADEL ADVISORS LLC previously held 0 shares of CRDF (CARDIFF ONCOLOGY INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$2.2M

Total Shares Change

-156,111

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.30
0
2026-Q1
Increased
125,566
+6.2%
$203,4170.0%$1.89
17
2025-Q4
Increased
118,188
+428.4%
$332,1080.0%$2.87
26
2025-Q3
New
22,365
-
$46,0720.0%$2.08
31
2025-Q2
Exited
0
-100.0%
$00.0%$3.15
0
2025-Q1
Increased
757,840
+992.7%
$2.4M0.0%$3.29
42
2024-Q4
Increased
69,353
+37.2%
$300,9920.0%$4.26
31
2024-Q3
Decreased
50,546
-9.4%
$134,9580.0%$2.77
0
2024-Q2
New
55,796
-
$123,8670.0%$2.22
34
2024-Q1
Exited
0
-100.0%
$00.0%$5.34
0
2023-Q4
New
27,760
-
$41,0850.0%$1.48
31
2023-Q3
Exited
0
-100.0%
$00.0%$1.39
0
2023-Q2
Increased
86,123
+1129.1%
$126,6010.0%$1.47
24
2023-Q1
Increased
7,007
+22.6%
$11,5620.0%$1.65
14
2022-Q4
Decreased
5,716
-97.2%
$8,0020.0%$1.40
0
2022-Q3
Increased
200,260
+54.6%
$308,0000.0%$1.54
33
2022-Q2
Decreased
129,497
-78.5%
$285,0000.0%$2.19
0
2022-Q1
Increased
602,477
+267.1%
$1.5M0.0%$2.47
41
2021-Q4
Decreased
164,123
-81.3%
$987,0000.0%$6.21
0
2021-Q3
Decreased
876,648
-25.9%
$5.8M0.0%$6.55
0
2021-Q2
Decreased
1.2M
-8.9%
$7.9M0.0%$7.20
0
2021-Q1
Increased
1.3M
+49.8%
$12M0.0%$9.10
39
2020-Q4
Increased
866,965
+455.4%
$15.6M0.0%$17.50
45
2020-Q3
New
156,111
-
$2.2M0.0%$14.01
36

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used